Cognitive Impairment in Patients with Immune Thrombocytopenia
Camelia Vladescu(Hammersmith Hospital), Nichola Cooper(Imperial College London), Sandra Sigudu(Imperial College Healthcare NHS Trust), Adam Waldman(Royal Society of Edinburgh), James B. Bussel(Cornell University), Ariam Teklemichael(Imperial College Healthcare NHS Trust), Christine Ademokun(Imperial College Healthcare NHS Trust), Anastastia Gontsarova(Imperial College Healthcare NHS Trust), Bridget Chivers(Imperial College Healthcare NHS Trust), Vashti Ragoonanan(Imperial College Healthcare NHS Trust), Alice C J Hart(Hammersmith Hospital), Naghma Rizvi(Imperial College Healthcare NHS Trust), Richard Syzdlo(Imperial College London), Deena Paul(Hammersmith Hospital), Billy J. Hopkins(Imperial College Healthcare NHS Trust)
Cited by 1
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial
|The Lancet Neurology|2008|774
B cell–helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen
|Nature Immunology|2011|724
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
|The Lancet Oncology|2011|649
AMG 531, a Thrombopoiesis-Stimulating Protein, for Chronic ITP
|New England Journal of Medicine|2006|530